A citation-based method for searching scientific literature

Jean-Pierre Bassand, Patricia N Apenteng, Dan Atar, A John Camm, Frank Cools, Ramon Corbalan, David A Fitzmaurice, Keith Aa Fox, Shinya Goto, Sylvia Haas, Werner Hacke, Carlos Jerjes-Sanchez, Yukihiro Koretsune, Jean-Yves Le Heuzey, Jitendra Ps Sawhney, Seil Oh, Janina Stępińska, Vincent Ten Cate, Freek Wa Verheugt, Gloria Kayani, Karen S Pieper, Ajay K Kakkar, For The Garfield-Af Investigators. Future Cardiol 2021
Times Cited: 3







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


The uncertainty principle and industry-sponsored research.
B Djulbegovic, M Lacevic, A Cantor, K K Fields, C L Bennett, J R Adams, N M Kuderer, G H Lyman. Lancet 2000
333
33


The Changing Landscape for Stroke Prevention in AF: Findings From the GLORIA-AF Registry Phase 2.
Menno V Huisman, Kenneth J Rothman, Miney Paquette, Christine Teutsch, Hans-Christoph Diener, Sergio J Dubner, Jonathan L Halperin, Chang Sheng Ma, Kristina Zint, Amelie Elsaesser,[...]. J Am Coll Cardiol 2017
185
33

Comparative effectiveness of oral anticoagulants in everyday practice.
A John Camm, Keith A A Fox, Saverio Virdone, Jean-Pierre Bassand, David A Fitzmaurice, Samuel I Berchuck, Bernard J Gersh, Samuel Z Goldhaber, Shinya Goto, Sylvia Haas,[...]. Heart 2021
7
33

Effectiveness and Safety of Direct Oral Anticoagulants in Relation to Temporal Changes in Their Use.
So-Ryoung Lee, Eue-Keun Choi, Soonil Kwon, Jin-Hyung Jung, Kyung-Do Han, Myung-Jin Cha, Seil Oh, Gregory Y H Lip. Circ Cardiovasc Qual Outcomes 2020
4
33

Evolving antithrombotic treatment patterns for patients with newly diagnosed atrial fibrillation.
A John Camm, Gabriele Accetta, Giuseppe Ambrosio, Dan Atar, Jean-Pierre Bassand, Eivind Berge, Frank Cools, David A Fitzmaurice, Samuel Z Goldhaber, Shinya Goto,[...]. Heart 2017
159
33

Welcome to the cardiovascular outcomes trials issue.
Craig I Coleman, Olivia S Costa. Future Cardiol 2021
1
100


Impact of expanded FDA indication for icosapent ethyl on enhanced cardiovascular residual risk reduction.
William E Boden, Seth Baum, Peter P Toth, Sergio Fazio, Deepak L Bhatt. Future Cardiol 2021
4
33

Sudden cardiac death in COVID-19 patients, a report of three cases.
Samira Shirazi, Sanaz Mami, Negar Mohtadi, Abas Ghaysouri, Hamed Tavan, Ali Nazari, Taleb Kokhazadeh, Reza Mollazadeh. Future Cardiol 2021
28
33

Acute type A aortic dissection in a patient with COVID-19.
Shiva Tabaghi, Mohammad Ali Akbarzadeh. Future Cardiol 2021
5
33



Dabigatran versus warfarin in patients with atrial fibrillation.
Stuart J Connolly, Michael D Ezekowitz, Salim Yusuf, John Eikelboom, Jonas Oldgren, Amit Parekh, Janice Pogue, Paul A Reilly, Ellison Themeles, Jeanne Varrone,[...]. N Engl J Med 2009
33

Apixaban versus warfarin in patients with atrial fibrillation.
Christopher B Granger, John H Alexander, John J V McMurray, Renato D Lopes, Elaine M Hylek, Michael Hanna, Hussein R Al-Khalidi, Jack Ansell, Dan Atar, Alvaro Avezum,[...]. N Engl J Med 2011
33


Shifts in the age distribution and from acute to chronic coronary heart disease hospitalizations.
Carla Koopman, Michiel L Bots, Ineke van Dis, Ilonca Vaartjes. Eur J Prev Cardiol 2016
13
33

Integrated management of atrial fibrillation in primary care: results of the ALL-IN cluster randomized trial.
Carline J van den Dries, Sander van Doorn, Frans H Rutten, Ruud Oudega, Sjef J C M van de Leur, Arif Elvan, Lisa Oude Grave, Henk J G Bilo, Karel G M Moons, Arno W Hoes,[...]. Eur Heart J 2020
25
33

Rivaroxaban versus warfarin in nonvalvular atrial fibrillation.
Manesh R Patel, Kenneth W Mahaffey, Jyotsna Garg, Guohua Pan, Daniel E Singer, Werner Hacke, Günter Breithardt, Jonathan L Halperin, Graeme J Hankey, Jonathan P Piccini,[...]. N Engl J Med 2011
33


Mortality after hospital admission for heart failure: improvement over time, equally strong in women as in men.
J Buddeke, G B Valstar, I van Dis, F L J Visseren, F H Rutten, H M den Ruijter, I Vaartjes, M L Bots. BMC Public Health 2020
12
33



Frailty and Clinical Outcomes of Direct Oral Anticoagulants Versus Warfarin in Older Adults With Atrial Fibrillation : A Cohort Study.
Dae Hyun Kim, Ajinkya Pawar, Joshua J Gagne, Lily G Bessette, Hemin Lee, Robert J Glynn, Sebastian Schneeweiss. Ann Intern Med 2021
8
33


Safety of switching from vitamin K antagonist to non-vitamin K antagonist oral anticoagulant in frail elderly with atrial fibrillation: rationale and design of the FRAIL-AF randomised controlled trial.
Linda P T Joosten, Sander van Doorn, Arno W Hoes, Melchior C Nierman, Nynke M Wiersma, Huiberdina L Koek, Martin E W Hemels, Menno V Huisman, Kit C Roes, Rutger M van den Bor,[...]. BMJ Open 2019
5
33

Contraindications to anticoagulation therapy and eligibility for novel anticoagulants in older patients with atrial fibrillation.
Benjamin A Steinberg, Melissa A Greiner, Bradley G Hammill, Lesley H Curtis, Emelia J Benjamin, Susan R Heckbert, Jonathan P Piccini. Cardiovasc Ther 2015
52
33


International trends in clinical characteristics and oral anticoagulation treatment for patients with atrial fibrillation: Results from the GARFIELD-AF, ORBIT-AF I, and ORBIT-AF II registries.
Benjamin A Steinberg, Haiyan Gao, Peter Shrader, Karen Pieper, Laine Thomas, A John Camm, Michael D Ezekowitz, Gregg C Fonarow, Bernard J Gersh, Samuel Goldhaber,[...]. Am Heart J 2017
103
33

Predictive performance of the CHA2DS2-VASc rule in atrial fibrillation: a systematic review and meta-analysis.
S van Doorn, T P A Debray, F Kaasenbrood, A W Hoes, F H Rutten, K G M Moons, G J Geersing. J Thromb Haemost 2017
15
33

Underuse of oral anticoagulants in atrial fibrillation: a systematic review.
Isla M Ogilvie, Nick Newton, Sharon A Welner, Warren Cowell, Gregory Y H Lip. Am J Med 2010
681
33

Effect of Variation in Published Stroke Rates on the Net Clinical Benefit of Anticoagulation for Atrial Fibrillation.
Sachin J Shah, Mark H Eckman, Sara Aspberg, Alan S Go, Daniel E Singer. Ann Intern Med 2018
14
33

Projections on the number of individuals with atrial fibrillation in the European Union, from 2000 to 2060.
Bouwe P Krijthe, Anton Kunst, Emelia J Benjamin, Gregory Y H Lip, Oscar H Franco, Albert Hofman, Jacqueline C M Witteman, Bruno H Stricker, Jan Heeringa. Eur Heart J 2013
584
33

Edoxaban versus warfarin in patients with atrial fibrillation.
Robert P Giugliano, Christian T Ruff, Eugene Braunwald, Sabina A Murphy, Stephen D Wiviott, Jonathan L Halperin, Albert L Waldo, Michael D Ezekowitz, Jeffrey I Weitz, Jindřich Špinar,[...]. N Engl J Med 2013
33

Routine primary care data for scientific research, quality of care programs and educational purposes: the Julius General Practitioners' Network (JGPN).
Hugo M Smeets, Marlous F Kortekaas, Frans H Rutten, Michiel L Bots, Willem van der Kraan, Gerard Daggelders, Hanneke Smits-Pelser, Charles W Helsper, Arno W Hoes, Niek J de Wit. BMC Health Serv Res 2018
30
33

Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials.
Christian T Ruff, Robert P Giugliano, Eugene Braunwald, Elaine B Hoffman, Naveen Deenadayalu, Michael D Ezekowitz, A John Camm, Jeffrey I Weitz, Basil S Lewis, Alexander Parkhomenko,[...]. Lancet 2014
33


Antithrombotic Treatment Patterns in Patients with Newly Diagnosed Nonvalvular Atrial Fibrillation: The GLORIA-AF Registry, Phase II.
Menno V Huisman, Kenneth J Rothman, Miney Paquette, Christine Teutsch, Hans Christoph Diener, Sergio J Dubner, Jonathan L Halperin, Changsheng Ma, Kristina Zint, Amelie Elsaesser,[...]. Am J Med 2015
124
33


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.